34results about How to "Rapid and easy identification" patented technology

The present invention relates to isolated Porphorymonas gingivalis polypeptides and nucleotides. The polypeptides include;an amino acid sequence selected from the group consisting of SEQ. ID. NO. 265 to SEQ. ID. NO. 528, SEQ. ID. NO. 531 and SEQ. ID. NO. 532; oran amino acid sequence at least 85%, preferably at least 95%, identical to an amino acid sequence selected from the group consisting of SEQ. ID. NO. 265 to SEQ. ID. NO. 528, SEQ. ID. NO. 531 and SEQ. ID. NO. 532; orat least 40 amino acids having a contiguous sequence of at least 40 amino acids identical to a contiguous amino acid sequence selected from the group consisting of SEQ. ID. NO. 265 to SEQ. ID. NO. 528, SEQ. ID. NO. 531 and SEQ. ID. NO. 532.

A gripper and a method of handling of loads (2A), especially easily damageable goods, with a gripper provided with arms (6A, 7A) capable of clamping the load by applying a compressive force to the load wherein the compressive force applied to the load is adjusted on the basis of the slippage measured with one or several rotatable slip sensors between the load and contact pads (8A, 9A) arranged in the arms, wherein the method comprises following steps: providing drive signals to one or several drive units arranged to rotate the rotating parts, like rollers, of the sensors, monitoring the rotation of the rotating parts by means of the information received from the sensors, and determining the proper operation of the sensors and / or the contact between the contact pads and the load by means of the rotation information.

A method, system and computer program product for automatically rendering information on a display screen of a building information system. Following generation of a plan image, such as a floor or site plan image, the plan image is modified and subsequently rendered on the display screen. The plan image is modified by adjusting the contrast ratio of the plan image such that, when graphical elements, such as icons representing elevators, evacuation stairways and fire hydrants, are rendered on the display screen overlaying the modified plan image, the graphical elements are visually distinct from the modified plan image.

Provided herein are fusion proteins comprising a homeodomain fusion protein domain and a transcription modulator domain for treatment of various diseases or disorders such as cancer. The homeodomain fusion protein domain binds to a target gene and the transcription modulator domain either activates or represses gene transcription. The present invention also relates to polynucleotides encoding the fusion proteins, vectors comprising the polynucleotides, cells comprising the polynucleotides, vectors, or fusion proteins. Also provided are methods of use and compositions for delivery of the fusion proteins.

A cell analysis apparatus includes a test sample preparation part for preparing a test sample by treating an analyte with a dye for staining an intracellular substance of cells in the analyte, a detector for detecting scattered light and fluorescence from each cell in the test sample, and a controller for identifying living mononuclear cells based on the scattered light and the fluorescence detected by the detector. A cell analysis method includes preparing a test sample by treating the analyte with a dye for staining an intracellular substance of cells in the analyte; detecting scattered light and fluorescence from each cell in the test sample; and identifying living mononuclear cells based on the scattered light and the fluorescence detected.

A decontamination gel is provided consisting of a colloidal solution comprising 0.1% to 30% by mass, preferably 0.1% to 25% by mass, still more preferably from 5% to 25% by mass, even more preferably 8% to 20% by mass, based on the mass of the gel, of at least one inorganic viscosifying agent; 0.1 to 10 mol / L of gel, preferably 0.5 to 10 mol / L of gel, still more preferably 1 to 10 mol / L of gel of at least one active decontamination agent; 0.01% to 10% by mass, preferably 0.1% to 5% by mass based on the mass of the gel of at least one mineral pigment; optionally, 0.1% to 2% by mass based on the mass of the gel, of at least one surfactant; optionally, 0.05% to 5% by mass, preferably 0.05% to 2% by mass, based on the mass of the gel, of at least one super-absorbent polymer; and the balance of solvent.

A fuse box includes a main body, a plurality of fuses mounted on the main body, and a plurality of light emitting diodes each mounted on the main body and each electrically connected with a respective one of the fuses. Thus, when one of the fuses is fused, the respective light emitting diode will light to produce an indication effect, so that the operator can simultaneously identify the melted fuse easily and rapidly by indication of the respective light emitting diode, so as to replace the melted fuse, thereby facilitating maintenance of the fuse.

The present invention is directed to methods and compositions related to α7 acetylcholine nicotinic receptor genes, in particular, the human α7 nicotinic acetylcholine receptor gene. The human α7 nicotinic acetylcholine receptor gene is associated with the pathophysiological aspects of the disease schizophrenia. The present invention further provides methods and compositions to screen populations for abnormal α7 alleles, as well as methods and compositions for development of therapeutics.

A system passively identifies objects at large distances with an integrated two-dimensional pattern, spectral tailoring, and an imaging system. Encoded information allows objects of various origin and configuration to be easily and rapidly identified by optical means, but is invisible to the naked eye. The devices used for detecting the objects may be ground-based, airborne, or even satellite-based, and can track engagements of such marked objects in real-time. A tailored reflective surface at a specific wavelength band is applied to the exteriors of the objects to form a unique signature. A scanning system passively records the light emanating from the signature in the specific band, and recognizes the signature to discern what the object is based on a database of information.

The present invention is based upon the identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes selected from the group consisting of CH-1, CH-2, CH-3, CH-4, CH-5, CH-6, CH-7, CH-8, and CH-9 and amino acid sequences of their encoded proteins, as well as derivatives (e.g., fragments) and analogs thereof. The invention also provides therapeutic methods and pharmaceutical compositions which are based on the promotion or inhibition of the function of the differentially expressed genes. The invention further provides methods of diagnosis, prognosis and screening for a disposition for diseases or disorders associated with cardiac hypertrophy. Methods for screening for modulators of the protein products of the differentially expressed genes in cardiac hypertrophy tissue are additionally provided.

The present invention relates generally to immunization methods using recombinant viral vectors. In particular, the invention relates to methods and compositions for immunizing a subject with a nucleic acid molecule encoding an antigen of interest, wherein the nucleic acid molecule is delivered to the subject via a recombinant AAV virion.

Provided are a method and an apparatus for identifying computer system information which process banner information of an open port of a computer system, create a CPE tree by analyzing a CPE dictionary, and search keywords of respective levels of the CPE tree in a banner and generate one or more CPEs based on the CPE tree observing a format of the CPE dictionary to select CPEs which most match information of an operating system or an application program of a specific computer system among various CPE candidates and rapidly and easily identify CPE type vulnerability information which can interlock with CVE vulnerability information.

The invention provides a mammalian cDNA which encodes a mammalian Ankrd2V. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of muscle disorders such as muscle hypertrophy and particularly clear cell sarcoma. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.

The present invention is directed to methods and compositions related to α7 acetylcholine nicotinic receptor genes, in particular, the human α7 nicotinic acetylcholine receptor gene. The human α7 nicotinic acetylcholine receptor gene is associated with the pathophysiological aspects of the disease schizophrenia. The present invention further provides methods and compositions to screen populations for abnormal α7 alleles, as well as methods and compositions for development of therapeutics.